Sign in

NCT05763641Recruiting

TAD After Chemotherapy in Locally Advanced Breast Cancer

Target Axillary Dissection After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Source: ClinicalTrials.gov · Last updated 17 Sept 2026

Brief summary (registry, in English)

This is an observational study to validate target axillary dissection (TAD) in locally advanced tumors (cN2 and/or cT4).

Status (registry)
Recruiting
Study type
Observational
Enrollment
162 (estimated)
First submitted
28 Feb 2023
Start date
1 Feb 2021
Primary completion date
1 Dec 2026
Lead sponsor
Hospital Universitari de Bellvitge
NCT number
NCT05763641

What you commit to

  • Study type: Observational
  • Planned participants: 162
  • From 1 Feb 2021 to the primary completion date, 1 Dec 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients undergoing neoadjuvant endocrine therapy

Other

  • cN3 verified by imaging tests
  • N2 due to internal mammary involvement (N2b).
  • Tumors whose surrogate molecular subtype is luminal A.
  • Patients with local recurrences and metastatic tumors.

Who the study is looking for

  • Axillary lymph node metastasis proven by cytology
  • Clinical or radiological N2a (at least 4 suspicious lymph nodes on axillary ultrasound at diagnosis)
  • Extensive T4 subsidiary to axillary lymphadenectomy according to current clinical criteria
  • Neoadjuvant chemotherapy

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Hospital Clínico y Provincial de Barcelona
Coordinator of this site? Confirm its status
BarcelonaSpainRecruiting
Hospital de Bellvitge
Coordinator of this site? Confirm its status
L'Hospitalet de LlobregatSpainRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.